title: Cross-protection is crucial for prophylactic HPV vaccination.
authors.affiliation: University of Tampere, Kalevantie 4, FI-33014, Finland. matti.lehtinen@uta.fi
authors.forename: Matti
authors.initials: M
authors.lastname: Lehtinen
mesh_terms: D056738:Cross Protection; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000276:immunology*
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines; C510352:human papillomavirus vaccine, L1 type 16, 18